Teriparatide Dosage Guide
95/100 confidenceComplete guide to Teriparatide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
20 mcg
Route
subq
Frequency
1x daily
Detailed Dosage Information
20mcg subcutaneously once daily. Maximum treatment duration of 2 years due to theoretical osteosarcoma risk from rat studies.
Administration Method
Subcutaneous injection in thigh or abdomen once daily. Delivered via multi-dose pen. Should sit or lie down after injection due to orthostatic hypotension risk.
Research Backing
Full FDA prescribing information \+ pivotal fracture-prevention RCTs (NEJM); decades of bone-density data.
Side Effects to Monitor
Orthostatic hypotension, leg cramps, nausea, dizziness, headache, and injection site reactions. Transient hypercalcemia possible.
Safety Considerations & Risks
Boxed warning for osteosarcoma risk (seen in rat studies at high doses). Contraindicated in Paget's disease, unexplained elevated ALP, prior bone radiation, or bone metastases.